Novel third-generation pyrimidines-based EGFR tyrosine kinase inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
Baijiao An, Jian Liu, Yangyang Fan, Wenyan Nie, Chunhua Yang, Han Yao, Wěi Li, Yin Zhang, Xingshu Li, Geng Tian
Topics & Concepts
T790MEpidermal growth factor receptorChemistryCancer researchTyrosine kinaseEGFR inhibitorsCell growthApoptosisKinaseCancerGefitinibPharmacologySignal transductionReceptorBiologyMedicineBiochemistryInternal medicineLung Cancer Treatments and MutationsCancer therapeutics and mechanismsHER2/EGFR in Cancer Research